Franz diffusion cell apparatus.

2. Scope

This SOP applies to the Analytical Method Development (AMD) team responsible for assessing the release and permeation profiles of creams, gels, ointments, lotions, and transdermal patches under controlled lab conditions.

3. Responsibilities

• Analytical Scientist: Develops method protocol, selects membrane type, and evaluates diffusion profiles.
• Lab Analyst: Prepares membranes, samples, maintains apparatus conditions, and performs sample collection.
• QA Officer: Reviews test setup, data integrity, and regulatory compliance.
• Head – AMD: Approves final IVPT method and ensures regulatory alignment for submissions.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that IVPT studies are performed with scientific rigor, reproducibility, and regulatory compliance.

5. Procedure

5.1 Equipment and Setup

1. Use vertical Franz diffusion cells with receptor volume: 5–10 mL and effective diffusion area: 0.64–2.0 cm².
2. Maintain receptor fluid temperature at 32 ± 1°C (skin surface temperature).
3. Use magnetic stirrers to maintain receptor fluid homogeneity (300–600 rpm).

5.2 Membrane Selection and Preparation

1. Select appropriate membranes:
   • Synthetic (e.g., cellulose acetate, PVDF) for release studies.
   • Biological (e.g., porcine skin, human cadaver skin) for permeation studies.
2. Hydrate synthetic membranes in receptor fluid for at least 1 hour before use.
3. For biological membranes, thaw, inspect integrity, and equilibrate as per protocol.

5.3 Receptor Medium

1. Select receptor fluid (e.g., PBS, ethanol-PBS mix) based on solubility and sink conditions.
2. Degas medium and filter using 0.22 µm membrane before filling cells.

5.4 Application of Test Product

1. Accurately weigh required dose of test sample (typically 2–5 mg/cm² for semi-solids).
2. Evenly apply on the donor side of membrane using a spatula or dosing ring.
3. Cover donor compartment with Parafilm to prevent evaporation.

5.5 Sample Collection and Analysis

1. Withdraw fixed volume (e.g., 200 µL) of receptor fluid at predetermined time intervals (e.g., 0.5, 1, 2, 4, 6, 8 hours).
2. Replace withdrawn volume with fresh, pre-warmed receptor fluid.
3. Analyze samples using validated HPLC or UV method to quantify drug content.
4. Document in Annexure-1: IVPT Sample Log.

5.6 Data Analysis

1. Calculate cumulative amount permeated per unit area (µg/cm²).
2. Plot cumulative permeated amount vs. time to determine flux (µg/cm²/h).
3. Calculate lag time and steady-state permeability coefficient (Kp).
4. Summarize in Annexure-2: IVPT Calculation Sheet.

5.7 Method Validation

1. Validate IVPT method as per EMA and FDA guidelines:
   • Precision: RSD ≤ 10% between replicate cells.
   • Recovery: 90%–110% recovery from receptor fluid.
   • Linearity: R² ≥ 0.99 for standard curve.
   • Sensitivity: LLOQ should detect lowest permeated concentration.
   • Robustness: Reproducibility with different analysts or membranes.
2. Compile data in Annexure-3: IVPT Validation Summary.

6. Abbreviations

• IVPT: In-Vitro Permeation Testing
• PVDF: Polyvinylidene Fluoride
• PBS: Phosphate Buffered Saline
• Kp: Permeability Coefficient
• SOP: Standard Operating Procedure

7. Documents

1. IVPT Sample Log – Annexure-1
2. IVPT Calculation Sheet – Annexure-2
3. IVPT Validation Summary – Annexure-3

8. References

• FDA Guidance on Topical and Transdermal Drug Products — IVPT Studies
• EMA Guideline on Quality of Topical Products
• ICH Q2(R2) – Validation of Analytical Procedures
• USP <1724> – Semisolid Drug Product Performance Tests

9. SOP Version

Version: 2.0

10. Approval Section

	Prepared By	Checked By	Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: IVPT Sample Log

Sample ID	Time Point (h)	Volume Withdrawn (µL)	Concentration (µg/mL)	Analyst
TP-102	2	200	14.6	Rajesh Kumar

Annexure-2: IVPT Calculation Sheet

Time (h)	Cumulative Amount (µg/cm²)	Flux (µg/cm²/h)	Kp (cm/h)
2	25.6	12.8	0.0041

Annexure-3: IVPT Validation Summary

Parameter	Result	Criteria	Status
Precision	RSD = 7.2%	≤ 10%	Pass
Recovery	103%	90%–110%	Pass

Revision History:

Revision Date	Revision No.	Details	Reason	Approved By
04/05/2025	2.0	Revised sampling intervals and included application of steady-state calculations	Annual SOP Review